EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice

Fulya Erendor iD, Fatih Uzer, Salih Sanlioglu iD

Biotechnology Journal · 2026

DOI: 10.1002/biot.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Fulya Erendor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gene and Cell Therapy, Faculty of Medicine, Akdeniz University, Antalya, Türkiye. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19 Vaccines, Adenoviridae, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KOSGEB R&D, Innovation and Support Program, Akdeniz University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global SARS‐CoV‐2 pandemic has underlined the urgent need for effective vaccine platforms. Adenoviral vectors have gained attention due to their high transgene capacity, broad tissue tropism, and innate immunostimulatory properties. This study aimed to develop and evaluate a recombinant adenoviral vaccine, Ad5Spike, encoding the full‐length SARS‐CoV‐2 Spike glycoprotein. The Ad5Spike vector was generated using Gateway Cloning Technology and produced by transient calcium phosphate‐mediated transfection of 293A cells. Viral particles (VP) were purified via CsCl density gradient ultracentrifugation. Female BALB/c mice (6–8 weeks old, n = 5 per group per timepoint) were immunized intraperitoneally with 10 8 , 10 10 , or 10 1 2 viral particles. Humoral and cellular immune responses were evaluated at 30‐ and 90‐days post‐immunization using ELISA, ELISpot, and pseudovirus neutralization assays. Ad5Spike vaccination induced measurable anti‐Spike IgG responses, with persistent antibody levels observed up to 90 days. Splenocyte analysis revealed elevated IFN‐γ, TNF‐α, and IL‐2 secretion, consistent with initial humoral and cellular activation. Neutralizing antibody activity against a lentiviral pseudovirus bearing the SARS‐CoV‐2 Spike (Wuhan‐1) was dose‐dependent and highest in the 10 1 2 group. In conclusion, this early preclinical study demonstrates that the Ad5Spike vaccine elicited detectable humoral and cellular immune responses, providing a proof‐of‐concept for the immunogenicity of this adenoviral‐based platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCOVID-19 VaccinesAdenoviridaeAntibodies, ViralCytokinesAnimalsFemaleMice, Inbred BALB CMiceSARS-CoV-2COVID-19Antibodies, NeutralizingHumansGenetic VectorsImmunity, Cellular

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2adenovirusspike glycoproteinvaccination

Substanzen

Spike Glycoprotein, CoronavirusCOVID-19 Vaccinesspike protein, SARS-CoV-2Antibodies, ViralCytokinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Gene and Cell Therapy, Faculty of Medicine, Akdeniz University, Antalya, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Ordu University, Ordu, Türkiye.
  • Department of Respiratory Diseases, Akdeniz University Medical School, Antalya, Türkiye.

ORCID-Profile: Fulya Erendor, Salih Sanlioglu

Förderung

  • KOSGEB R&D, Innovation and Support Program
  • Akdeniz University Scientific Research Projects Coordination Unit

Zitieren

APA

Erendor, F., Uzer, F., & Sanlioglu, S. (2026). An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice. Biotechnology Journal. https://doi.org/10.1002/biot.70216

Vancouver

Erendor F, Uzer F, Sanlioglu S. An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice. Biotechnology Journal. 2026. doi:10.1002/biot.70216

BibTeX
@article{Erendor2026,
  author = {Erendor, Fulya and Uzer, Fatih and Sanlioglu, Salih},
  title = {An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice},
  journal = {Biotechnology Journal},
  year = {2026},
  doi = {10.1002/biot.70216}
}
Kostenlos starten →